Within the tumour microenvironment (TME), the enrichment of eATP released from stressed or dying tumour cells could stimulate cell inflammation activity, including NLRP3 inflammasome activation, thus triggering the activation of T cells [10]. Here, NLRP3 is linked to neoplasm.